Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Socio-Economic Panel, German Institute for Economic Research, Berlin, Germany.
Int J Public Health. 2023 Sep 14;68:1606152. doi: 10.3389/ijph.2023.1606152. eCollection 2023.
To evaluate the socioeconomic patterns of SARS-CoV-2 antigen contacts through infection, vaccination or both ("hybrid immunity") after 1 year of vaccination campaign. Data were derived from the German seroepidemiological Corona Monitoring Nationwide study (RKI-SOEP-2; = 10,448; November 2021-February 2022). Combining serological and self-report data, we estimated adjusted prevalence ratios (PR) of SARS-CoV-2 infection, COVID-19 vaccination, basic immunization (at least two SARS-CoV-2 antigen contacts through vaccination and/or infection), and three antigen contacts by education and income. Low-education groups had 1.35-times (95% CI 1.01-1.82) the risk of SARS-CoV-2 infection compared to high-education groups. COVID-19 vaccination (at least one dose) and basic immunization decreased with lower education and income. Low-education and low-income groups were less likely to have had at least three antigen contacts (PR low vs. high education: 0.74, 95% CI 0.65-0.84; PR low vs. high income: 0.66, 95% CI 0.57-0.77). The results suggest a lower level of protection against severe COVID-19 for individuals from low and medium socioeconomic groups. Pandemic response and vaccination campaigns should address the specific needs and barriers of these groups.
评估接种疫苗一年后,通过感染、接种疫苗或两者结合(“混合免疫”)而接触 SARS-CoV-2 抗原的社会经济模式。数据来自德国血清流行病学冠状病毒全国监测研究(RKI-SOEP-2;n=10448;2021 年 11 月至 2022 年 2 月)。通过结合血清学和自我报告数据,我们估计了 SARS-CoV-2 感染、COVID-19 疫苗接种、基础免疫(至少通过接种和/或感染与 SARS-CoV-2 抗原接触两次)以及通过教育和收入的三种抗原接触的调整后患病率比(PR)。与高学历组相比,低学历组感染 SARS-CoV-2 的风险高 1.35 倍(95%CI 1.01-1.82)。COVID-19 疫苗接种(至少一剂)和基础免疫随着教育和收入的降低而减少。低教育和低收入群体不太可能有至少三次抗原接触(低 vs. 高教育 PR:0.74,95%CI 0.65-0.84;低 vs. 低教育收入 PR:0.66,95%CI 0.57-0.77)。结果表明,来自中低社会经济群体的个体对严重 COVID-19 的保护水平较低。大流行应对和疫苗接种活动应针对这些群体的特定需求和障碍。
J Epidemiol Community Health. 2022-4
Glob Health Action. 2024-12-31
Int J Public Health. 2024
Lancet Public Health. 2022-11
Int J Equity Health. 2022-8-30